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Abstract: Investigation of the chemical profile of the industrially important black 
filamentous fungus Aspergillus aculeatus by UHPLC-DAD-HRMS and subsequent 
dereplication has led to the discovery of several novel compounds. Isolation and extensive 
1D and 2D NMR spectroscopic analyses allowed for structural elucidation of a 
dioxomorpholine, a unique okaramine, an aflavinine and three novel structures of mixed 
biosynthetic origin, which we have named aculenes A–C. Moreover, known analogues of 
calbistrins, okaramines and secalonic acids were detected. All novel compounds were 
tested for antifungal activity against Candida albicans, however all showed only weak or 
no activity. Aspergillus aculeatus IBT 21030 was additionally shown to be capable of 
producing sclerotia. Examination of the sclerotia revealed a highly regulated production of 
metabolites in these morphological structures.  
Keywords: Aspergillus aculeatus; Aspergilli; natural products; secondary metabolism; 
dereplication; sclerotia 
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1. Introduction 
Aspergillus aculeatus is a filamentous fungus belonging to Aspergillus section Nigri—the black 
aspergilli. At least 145 metabolites have been characterized from the black aspergilli [1], many of which 
are biologically active. Naphtho-γ-pyrones (NGPs) such as aurasperone A and rubrofusarin B from A. 
niger are known to be antifungal [2], while other NGPs are reported to have antitumor activities [3]. 
Mycotoxins produced by A. niger, such as ochratoxin A [4] or the fumonisins [5] are also known.  
The black aspergilli can be divided into different clades. A. aculeatus belongs to the uniseriate  
black aspergilli and is closely related to A. aculeatinus, A. uvarum, A. japonicus, A. fijiensis,  
A. trinidadensis, A. floridensis, A. brunneoviolaceus and A. violaceofuscus [6,7]. These fungi differ 
from the other black aspergilli in their morphology, physiological behavior and in the production of 
secondary metabolites. The fungi belonging to this group can produce secondary metabolites, which can 
be both polyketide (PK) and nonribosomal peptide (NRP) derived or of mixed biosynthetic origin [1]. 
Several metabolites, including aculeacins A–G [8,9], CJ-15,183 [10], secalonic acids D and F [11] and 
okaramines H and I [12], have been reported in fungi identified as A. aculeatus. Furthermore, 
asperaculin A [13], aspergillusol A [14] and aculeatusquinones A–D [15] have been reported in marine 
strains of A. aculeatus. Different biological activities are reported for these metabolites, including 
antifungal (aculeacins A-G and CJ-15,183), enzyme inhibitory (CJ-15,183 and aspergilluson A), 
antimicrobial activities (secalonic D and F) and cytotoxicity (aculeatusquinone B and D). 
While some black aspergilli are important in the biotechnological industry for production of 
enzymes and organic acids [16,17], some species can also be food and feed contaminants [18]. In fact, 
the black aspergilli are among the most common fungi connected to postharvest decay of fruit, beans 
and nuts, and A. aculeatus is no exception [18,19].  
A. aculeatus is used to produce important industrial enzymes such as cellulases [20],  
xylanases [21,22] and proteases [23], which are used commercially in the food and feed industries. 
Moreover a marine strain of A. aculeatus has tested active against Staphylococcus aureus [24]. Based 
on both the industrial applications of A. aculeatus as well as food and feed contamination hazards it is 
of great importance to know what metabolites are being produced by this fungus. The aim of the 
current work has been to investigate the chemical profile of A. aculeatus seeking to discover novel 
compounds and to test for the antifungal activity of its metabolites. 
2. Results and Discussion 
Initial analysis of the chemistry of A. aculeatus involved two strains (IBT 21030 and IBT 3244) 
which were investigated on a series of solid media (YES, CYA, MEA, OAT and CREA) [25]. The 
strains were cultivated at 25 and 30 °C in the dark for 7 days and were investigated with micro-scale 
extractions [26]. The secondary metabolite profiles were analyzed with UHPLC-DAD-HRMS, which 
demonstrated that the strains showed highly similar chemical profiles. However, more metabolites 
were produced by the A. aculeatus IBT 21030 strain, hence this strain was chosen for further work. 
The medium used in the cultivations had varying effect on metabolite production. While cultivation on 
MEA, OAT and CREA did not lead to diverse production, cultivation on both CYA and YES lead to 
production of several different metabolites. The YES medium was selected for further work, and it was 
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found that the optimal cultivation temperature was 25 °C. The A. aculeatus strain was inoculated on 
YES media and incubated at 25 °C and analyzed after 2, 4, 7, and 10 days to test the effect of 
incubation time on the metabolite production. These experiments showed that 7 days of incubation 
gave the optimum production of secondary metabolites. Based on these initial experiments,  
A. aculeatus was inoculated on 200 plates of YES and incubated at 25 °C for seven days in the dark. 
The results of the dereplication as well as isolation and elucidation of novel compounds are depicted  
in Figure 1. 
Figure 1. Base peak chromatogram illustrating the dereplication of some of the major 
compounds in the extract from A. aculeatus IBT 21030 as well as the results of purification 
and structural elucidation of novel compounds. Based on cultivation on YES media for  
7 days at 25 °C in the dark. * Novel compounds reported here for the first time.  
** Compounds reported from A. aculeatus for the first time. 
 
Dereplication was performed by UV- and HRMS-data to identify known compounds. An in-house 
library of microbial metabolites [27] as well as the AntiBase 2012 natural products database [28] were 
used for identification. Many of the major peaks could be dereplicated as compounds already known to 
be produced by A. aculeatus (Figures 1 and 2). This included secalonic acids D and F [11], as well as 
okaramines A and H [12]. One further okaramine was produced, which could not be unambiguously 
dereplicated, since the HRMS and UV data pointed towards either okaramine C, J or L. The compound 
was isolated and the structure was elucidated by 1D and 2D NMR and the structure was established to 
correspond to okaramine J, which has previously been described from Penicillium ochrochloron 
(formerly identified as Penicillium simplicissimum) [29,30]. 
Two calbistrin analogues could also be dereplicated from A. aculeatus. Calbistrins A–D, have been 
described from Penicillium restrictum by Jackson et al. [31] and the structures of the four compounds 
were later elucidated by the same group [32]. Calbistrin A is biologically active as an antifungal agent, 
a promoter of nerve growth factor production and a cholesterol lowering agent. Identification of the two 
calbistrins was not possible solely based on HRMS and DAD data, as calbistrins pairwise have the same 
molecular formula (A and B have the same molecular formula and likewise for calbistrins C and D). The 
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two compounds were therefore isolated and their structures elucidated by 1D and 2D NMR, and it was 
shown that the two compounds produced by A. aculeatus were calbistrin A and C, Figure 2. 
Figure 2. Known compounds dereplicated from A. aculeatus. Okaramines A and H as well 
as secalonic acids have previously been reported from the organism, whereas the 
calbistrins and okaramine J are reported from A. aculeatus for the first time. 
 
2.1. A Novel Class of Compounds, Named the aculenes, Has a Mixed Biosynthetic Origin 
The two major metabolites produced by A. aculeatus, aculenes A and B (Figure 1) have previously 
been detected by UHPLC-DAD-HRMS in the related black aspergillus A. saccharolyticus [33], but the 
structures have not been elucidated. The molecular formulae of the two compounds were determined 
by HRMS to be C19H25NO3 and C19H27NO3, respectively. The mass difference of 2 Da and the fact that 
the two compounds eluted very close to each other suggested that the compounds were related and 
only differed by a double bond. The UV-spectra differed greatly as depicted in Figure 3, indeed 
indicating aculene A to contain a more conjugated chromophore. 
The structures of the two compounds were elucidated by 1D- and 2D NMR spectroscopy and the 
structures of aculenes A and B are depicted in Figure 4. The conjugation in aculene A was in 
agreement with the recorded UV spectrum. The only difference with aculene B is the absent double 
bond between C-11 and C-12 and as seen, this structure was also in accordance with the obtained UV 
spectrum. The 1H-NMR spectra of both aculenes A and B revealed the presence of one Hα proton  
(H-5), which was found to be in a COSY spin system with three methylene groups (H-2, H-3 and H-4), 
which where elucidated as a proline ring. The remaining resonances in the 1H-NMR spectra belonged 
to a fused five and seven membered ring system. The linking between the COSY spin systems for this 
part and assignments of the quaternary carbons were accomplished through detailed analysis of the 
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HMBC experimental data. Some of the important HMBC correlations for the elucidation of aculene B 
are depicted in Figure 5. 
Figure 3. UV-spectra of selected A. aculeatus metabolites. The remaining UV spectra can 
be found in the Supporting Information. 
 
Figure 4. The structure of aculenes A–D. The structures of aculenes A–C have been 
verified by 1D and 2D NMR spectroscopy, whereas the structure of aculene D has been 
suggested based on UHPLC-DAD-HRMS data. The stereochemistry shown is relative. 
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Figure 5. A. Important HMBC correlations in the elucidation of aculene B.  
B. The NOEs used to solve the stereochemistry. Similar HMBCs and NOEs were observed 
for aculenes A and C, see Table 1 and Supplementary Table S2. 
 
Table 1. 1H-NMR spectroscopic data (500 and 800 MHz, DMSO-d6) and HMBCs for aculenes A–C. 
 Aculene A Aculene B Aculene C 
Position δH (J in Hz) HMBC δH (J in Hz) HMBC δH (J in Hz) HMBC 
1 - - - -   
2 3.15 (m) - 3.21 (m) 3,4,5   
2' 3.09 (m) - 3.14 (m) 3,4,5   
3 1.83 (m) - 1.84 (m) 2,4,5   
3' 1.67 (m) - 1.76 (m) 2,4,5   
4 1.94 (m) 2,6 2.05 (m) 2,3,5,6   
4' 1.46 (m) 2,6 1.55 (m) 2,6   
5 4.23 (t 7.7) 6 4.31 (t 7.8) 2,3,4,6   
6 - - - -   
7 5.33 (dd 4.4, 2.4) - 5.28 (dd 5.3, 2.3) 6,9,12,16 3.95 (t 3.5) 9,13,15 
8 2.82(br.d 20.8) - 2.67 (br. d 19.1) 16 2.52 (br. d 20.1)  
8' 2.55 (m) 9,10,16 2.37 (m) 7,9,10,16 2.31 (m) 7,9,10,16 
9 - - - - - - 
10 5.98 (d 7.4) 8,12,18 5.56 (m) 8,11,12,18 5.87 (d 7.3) 8,12,18 
11 6.24 (d 7.4) 9,13,16 2.12 (m) - 6.08 (d 7.4) 9,13,16 
11' - - 2.52 (m) 18 - - 
12 - - 3.31 (m) 10,11,14 - - 
13 - - - - - - 
14 6.03 (s) 
12,13,15,16,1
9 
5.81 (q 1.8) 12,13,15,16,19 5.93 (s) 
12,13,15,16,
19 
15 - - - - - - 
16 - - - - - - 
17 0.96 (s) 7,12,15,16 0.96 (s) 7,12,15,16 0.79 (s) 7,12,15,16 
18 1.85 (s) 8,9,10 1.68 (s) 8,9,10 1.82 (s) 8, 9,10 
19 2.55 (m) 13,20 2.39 (m) 13,14,20 2.48 (m) 12,13,14,20 
20 1.16 (t 7.4) 13,19 1.11 (t 7.3) 13,19 1.14 (t 7.4) 13,19 
-OH - - - - 4.43 (s) - 
The NMR data for aculene A were very comparable to those of aculene B (Tables 1 and 2), yet 
differences were observed corresponding to the additional double bond in aculene A. The chemical 
shift of H-10 and H-14 is seen to differ slightly and furthermore an additional resonance was present in 
the 1H-NMR spectrum in the aromatic/alkene area for compound A. This was located at a chemical 
O O
O
HNCH3
H
O O
O
HNCH3
H
(L)-pro
12
16
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5
17O O
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HNH
H
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shift of δH = 6.24 ppm and assigned H-11. The only other location where the spectrum differed 
significantly was due to the extra diastereotopic CH2 groups in the 7-membered ring of aculene B. For 
this, and the diastereotopic CH2 group H8/H8' present in both compounds, rather large coupling 
constants were observed due to the geminal coupling. In compound A the H-8 doublet had a coupling 
constant of 20.8 Hz. Another notable chemical shift is the carbon chemical shift of C-13. This was at 
δC = 175.3 and 183.8 ppm, respectively for the two compounds, which is rather far downfield.  
Table 2. 13C-NMR spectroscopic data (125 and 200 MHz, DMSO-d6) for aculenes A–C. 
Position 
Aculene A Aculene B Aculene C 
δC δC δC 
1 - - - 
2 45.1 44.7 - 
3 22.3 22.3 - 
4 27.6 27.6 - 
5 58.4 58.3 - 
6 168.0 167.8 - 
7 72.9 73.5 67.6 
8 36.5 35.5 40.2 
9 141.7 130.7 142.5 
10 120.0 122.7 119.7 
11 118.5 24.9 117.8 
12 142.5 44.6 144.3 
13 175.3 183.8 174.3 
14 125.3 122.8 125.6 
15 205.8 208.2 208.2 
16 51.7 54.4 53.6 
17 17.9 17.1 18.3 
18 26.9 28.3 27.1 
19 20.1 23.1 19.8 
20 12.0 10.8 11.8 
A third and related compound (aculene C) was also characterized. The UV spectrum was similar to 
the UV spectrum observed for aculene A (Figure 3) and the molecular formula was determined by 
HRMS to be C14H18O2. The NMR data was comparable to that of aculene A (Tables 1 and 2), though 
with an absence of resonances originating from the proline part. Elucidation of the structure revealed 
that the compound was related to the aculenes, therefore it was named aculene C (Figure 4). Aculene C 
is a likely precursor to aculene A, having the same carbon skeleton, but missing the proline moiety. 
Analysis of the UHPLC-DAD-HRMS data showed a fourth compound, eluting close by aculene C, 
present in minute amounts, with a mass difference of 2 Da compared to aculene C, and with a UV 
spectrum very similar to aculene B (Figure 3). The HRMS data displayed the same adducts and 
fragmentation pattern as observed for aculene C. This compound, aculene D, is believed to have a 
similar structure as aculene C, but with the absence of the double bond between C-11 and C-12, as 
seen with the relation between aculenes A and B. This structure has not been verified by  
NMR experiments. 
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The stereochemistry of aculenes A-C was elucidated by NOEs, J-couplings and Marfey’s reaction [34], 
from which it was determined that aculenes A and B contained L-proline. The stereocenters (C-5, C-7 
and C-16) of aculenes A and B could not be connected, due to lack of NOEs from the proline to the 
bicyclic system and the free rotation of proline. The relative stereochemistry of stereocenters C-7 and 
C-16, as well as C-12 for aculene B, is depicted in Figure 4, suggested by NOEs and backcalculated  
3J-couplings of H-7 (see Supplementary Figure S37 and Supplementary Tables S1 and S2). Relevant 
NOEs are depicted for aculene B in Figure 5. 
We hypothesize the biosynthesis of the aculenes to originate from a terpene pathway. Aculene C 
and D consist of fourteen carbons, which could originate from a sesquiterpene with the loss of one 
carbon atom, possibly at C9. Aculene A and B furthermore contain the amino acid proline. 
The two compounds marked as acucalbistrin A and B in Figure 1 were also targeted. These 
compounds were intriguing because they could not be dereplicated, and because the HRMS data 
suggested that the size were somewhat larger than typical secondary metabolites. The molecular 
formulas for the two compounds were determined to be C50H63NO10 and C50H65NO10, the mass spectra 
are depicted in Figure 6. 
Figure 6. Mass spectra of acucalbistrin A (top) and acucalbistrin B (bottom). A fragment 
corresponding to m/z of the molecular ion [M+H]+ of aculene A (*) and aculene B (**) are 
observed for acucalbistrin A and B respectively. 
 
A feature noted in both mass spectra was a fragment corresponding to the mass of aculenes A and 
aculene B, respectively. Different chromatographic approaches were taken to purify both compounds, 
which however proved challenging as the compounds were unstable even under mild conditions. 
Apparently acucalbistrin A was degrading to aculene A and another compound X, while acucalbistrin 
B was degrading to aculene B and the same compound X. Analysis by UHPLC-DAD-HRMS of a 
small semipreparative proportion of this degradation product revealed to our surprise this compound to 
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be calbistrin A. This was verified by the UHPLC-DAD-HRMS data by comparison to the known 
compounds, see Supplementary Figure S39. 
The combined mass of aculene A and calbistrin A is higher than that of acucalbistrin A (and the 
same for the case of acucalbistrin B), where the difference corresponds to a single water molecule. We 
therefore hypothezise that the acucalbistrins undergo hydrolysis and with knowledge on the structures 
of aculenes A–B and calbistrin A, a possible structure could therefore be an amide bond between the 
nitrogen in the proline moiety in aculene to the carbonyl in the carboxylic acid part of calbistrin A (see 
Supplementary Figure S38). This would account for the observed masses. These acucalbistrin structures 
have not been verified by NMR spectroscopy. We note that the UV spectra of acucalbistrin A and B 
have UVmax values comparable to those observed for calbistrin A (Figure 3). The slight shift observed 
may be due to the aculene moiety being attached directly to the carboxylic acid, which is part of the 
conjugated system in calbistrin A. The proposed structures are given in Supplementary Figure S38. 
2.2. Discovery of Novel Indole Terpenoids 
Three other compounds were isolated and structure elucidated resulting in the novel compounds 
acu-dioxomorpholine, okaramine S and epi-10,23-dihydro-24,25-dehydroaflavinine with the structures 
shown in Figure 7. 
Figure 7. The structure of acu-dioxomorpholine, okaramine S and epi-10,23-dihydro-
24,25-dehydroaflavinine. 
 
NMR data for the compounds are presented in Table 3, Table 4, and Table 5, respectively. The 
structure of acu-dioxomorpholine reminds one of a diketopiperazine, but this structure differs in that it 
contains a lactone. The chemical shift of the proton adjacent to the lactone oxygen (H-3) clearly differs 
compared to the chemical shift of a proton in ordinary diketopiperazines, which is typically reported to 
be around δH = 3.50–4.50 ppm [35,36]. For acu-dioxomorpholine the proton chemical shift is  
δH = 5.32 ppm. The carbon chemical shift of C-3 is also shifted significantly downfield, with δC = 78.1 
ppm for the acu-dioxomorpholine, compared to around 60 ppm for diketopiperazines. Two compounds 
have been reported by Wang et al. with the same lactone feature [37], but differ by having leucine 
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incorporated instead of phenylalanine and by lacking the N-methylation. Otherwise the NMR data  
are comparable.  
NOESY experiments enabled determination of the relative stereochemistry of acu-dioxomorpholine. 
NOE connectivities were found between H-3 and H-16 placing these protons on the same side of the 
ring system. These had no NOE connectivities to H-6, which however displayed NOE connectivities to 
H-22 as well as several of the protons in the prenyl moiety (H-18, H-19, H-19' and H-20), strongly 
indicating the positioning of the prenyl group and H-6 on the other side of the ring system as compared 
to H-3 and H-16. 
Table 3. NMR spectroscopic data (500 and 800 MHz, DMSO-d6) for acu-dioxomorpholine. 
Position δH (J in Hz) δC  HMBC Noesy 
1 - 168.0 - - 
2 2.96 (3H, s) 32.7 6, 8 6,9 
3 5.32 (1H, dd, 8.8, 3.4) 78.1 4, 22, 23 16, 22, 22', 24/28 
4 - 163.5 - - 
5 - - - - 
6 5.43 (1H, s) 81.9 2, 4, 8, 13, 14, 15, 16, 17 12, 18, 19, 19', 20, 22 
7 - - - - 
8 - 150.8 - - 
9 6.44 (1H, d, 7.6) 105.6 11, 13 2, 10 
10 7.09 (1H, td, 7.6, 0.8) 128.5 8, 12 9, 11 
11 6.64 (1H, t, 7.3) 116.9 9, 12, 13 10, 12 
12 7.17 (1H, d, 7.3) 124.1 8, 10, 14 11, 15, 18, 20, 21 
13 - 128.8 - - 
14 - 59.6 - - 
15 2.43 (1H, dd, 12.7, 6.6) 36.6 1, 6, 13, 14, 16 12, 15', 16 
15' 2.21 ( 1H, dd, 12.7, 11.1) 36.6 1, 13, 14, 16 15, 16, 18, 20, 21 
16 4.17 (1H, dd, 11.1, 6.6) 56.7 1, 15 3, 15, 15' 
17 - 40.1 - - 
18 5.87 (1H, dd, 17.4, 11.0) 143.3 14, 17, 21 6, 12, 15', 19, 19', 20, 21 
19 5.02 (1H, dd, 17.4, 1.1) 113.7 14, 17, 18  6, 18, 19', 20, 21 
19' 5.06 (1H, dd, 11.0, 1.1) 113.6 14, 17, 18 6, 18, 19, 20, 21 
20 0.82 (3H, s) 22.4 14, 17, 18, 21 6, 12, 15', 18, 19, 19', 21 
21 0.97 (3H, s) 21.7 14, 17, 18, 20 12, 15', 18, 19, 19', 20 
22 2.98 (1H, dd, 14.8, 8.8) 34.9 3, 4, 23, 28 3, 6, 22', 24/28 
22' 3.33 (1H, m) 34.9 3, 4, 23, 28 3, 22, 24/28 
23 - 136.3 - - 
24 7.26 (1H, m) 129.2 22, 26, 28 3, 22, 22' 
25 7.28 (1H, m) 127.7 - 26 
26 7.22 (1H, tt, 7.2, 1.6) 126.2 28 25 
27 7.28 (1H, m) 127.7 23, 25 - 
28 7.26 (1H, m) 129.2 - 3, 22, 22' 
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Table 4. NMR spectroscopic data (500 and 800 MHz, DMSO-d6) for okaramine S. 
Position δH (J in Hz) δC  Hmbc Noesy 
1 7.64 (1H, s) 114.7 2, 4, 14, 15 - 
2 - 123.8 - - 
4 - 137.6 - - 
5 4.26 (1H, q, 6.5) 43.2 4, 14, 18 18 
6 - 51.2 - - 
7 5.87 (1H, s) - 5, 9, 13, 17 9 
8 - 144.5 - - 
9 6.90 (1H, d, 7.6) 118.8 11, 13 10 
10 6.99 (1H, t, 7.6) 127.4 8, 12 9 
11 6.65 (1H, t, 7.6) 116.8 9, 13 12 
12 7.74 (1H, d, 7.6) 128.3 8, 10, 14 1,11 
13 - 115.3 - - 
14 - 124.9 - - 
15 - 153.4 - - 
16 0.95 (3H, s) 27.1 5, 6, 17 17 
17 1.39 (3H, s) 29.3 5, 6, 16 16 
18 1.18 (3H, d, 7.2) 18.1 4, 5, 6 - 
19 7.76 (1H, s) 117.5 20, 25, 32, 33, 34 - 
20 - 125.2 - - 
22 5.90 (1H, d, 8.3) 123.6 23, 24 23 
23 6.15 (1H, d, 8.3) 140.2 22, 24, 35/36 22 
24 - 35.8 - - 
25 - 149.8 - - 
26 11.70 (1H, s) - 25, 32, 33 - 
27 - 134.2 - - 
28 7.44 (1H, m) 112.3 - 29/30 
29 7.17 (1H, m) 121.7 31 28, 31 
30 7.17 (1H, m) 121.7 31 28, 31 
31 7.63 (1H, m) 116.1 27, 29/30 12, 29/30 
32 - 105.3 - - 
33 - 129.5 - - 
34 - 157.6 - - 
35 1.69 (3H, s) 26.7 23, 24, 25, 35/36 - 
36 1.69 (3H, s) 26.7 23, 24, 25, 35/36 - 
For okaramine S the molecular formula was by HRMS predicted to be C32H30N4O2. The 
azocinoindole part of the novel okaramine (Figure 7) is identical to that observed in okaramines A and 
H (Scheme 1), also produced by A. aculeatus [12]. The remaining part is highly similar, also 
originating from tryptophan and an isoprene unit, but in okaramine S, the terpene is fused with the ring 
system of the tryptophan moiety resulting in an intriguing, additional seven-membered ring, not 
previously reported in any okaramine. Key HMBCs from this part of okaramine S are depicted  
in Figure 8. 
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Table 5. NMR spectroscopic data (500 MHz, DMSO-d6) for epi-10,23-dihydro-24,25-
dehydroaflavinine. 
Position δH (J in Hz) δC  HMBC H2BC NOESY 
1 10.66 (s) - 2, 3, 4, 9 2 2,8 
2 7.07 (d 2.0) 122.7 3, 4, 9 - 1, 23, 25, 27 
3 - 114.4 - -  
4 - 126.7 - -  
5 7.38 (d 7.8) 116.8 7, 9 6 10, 11, 18 
6 6.96 (t 7.2) 117.7 4, 8 5, 7  
7 7.02 (t 7.3) 120.0 5, 9 6, 8  
8 7.29 (d 8.0) 110.9 4, 6 7 1 
9 - 135.5 - -  
10 3.59 (dd 13.3, 5.0) 33.4 2, 3, 11, 12, 23, 24 11, 23 5, 11, 19, 25, 26 
11 2.47 (m) 37.6 10, 12, 23 10, 12 5, 10, 12, 13, 16, 19 
12 1.27 (m) 28.9 - 17 11 
13 1.53 (m) 28.1 29 - 11, 13', 16 
13' 0.81 (d 12.9) 28.1 - - 13 
14 1.46 (m) 27.4 - -  
14' 1.08 (d 13.7) 27.4 27 - 28 
15 - 38.2 - -  
16 2.04 (m) 30.4 - 17, 28 11, 13, 17', 28 
17 1.71 (m) 24.8 - 18  
17' 1.22 (m) 24.8 - -  
18 1.99 (d 11.3) 29.6 - - 5, 19 
18' 1.74 (m) 29.6 - - 19, 30 
19 4.64 (s) 65.6 - - 10, 11, 18, 18', 22, 26
20 - 42.9 - -  
21 2.07 (m) 23.5 - - 29, 30 
21' 1.65 (m) 23.5 19, 23 - 27 
22 1.85 (m) 26.6 20, 24 21, 23 19, 30 
22' 1.54 (m) 26.6 - -  
23 3.13 (m) 42.3 24, 25, 26 10, 22 2, 25, 27 
24 - 149.8 - -  
25 4.81 (d 1.8) 110.4 23, 26 26 2, 10, 23, 25' 
25' 4.58 (d 1.8) 110.4 23, 26 26 25, 26 
26 1.45 (s) 17.7 23, 24, 25 - 10, 19, 25' 
27 1.21 (s) 21.1 11, 12 12 2, 21', 23 
28 0.71 (d 6.7) 15.4 15, 16, 17 16 14', 16, 17' 
29 0.92 (s) 17.7 13, 15, 16, 20 - 17, 21, 30 
30 4.28 (d 4.3) - 19, 20 19 18', 21, 22, 29 
The molecular formula of the aflavinine analogue was predicted by HRMS to be C28H39NO  
and dereplication indicated it could be aflavinine or an analogue. Since no aflavinine or analogue was 
previously described in A. aculeatus, this compound was also a target for isolation and structural 
elucidation. The NMR data, see Table 5, suggested the structure of 10,23-dihydro-24,25-dehydroaflavinine. 
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Figure 8. Key HMBCs substantiating the seven-membered ring in okaramine S. 
 
10,23-Dihydro-24,25-dehydroaflavinine has earlier been reported from sclerotia from A. flavus,  
A. parasiticus and A. tubingensis [38]. The compound has not been reported from A. aculeatus, but it is 
known to be produced by the related black Aspergillus A. costaricaensis [39]. The stereochemistry of 
epi-10,23-dihydro-24,25-dehydroaflavinine was solved by the use of NOEs and J-couplings. The 
relative stereochemistry was found to be equal to that of 10,23-dihydro-24,25-dehydroaflavinine [38]. 
For investigation of the absolute configuration of the purified compound, optical rotation was measured. 
Two different values were obtained, [α] = 63.58° and [α] = 9.08° in MeOH and CHCl3 respectively. 
These values were compared to the value of [α]D = −1.20°, which has earlier been reported for  
10,23-dihydro-24,25-dehydroaflavinine in CHCl3 [38]. Due to those opposite signs, our result suggests that 
the compound from A. aculeatus is the enantiomer of 10,23-dihydro-24,25-dehydroaflavinine, 
wherefore we have named it epi-10,23-dihydro-24,25-dehydroaflavinine. The 3D structure (see 
Supplementary Figure S40) was suggested by the isolated spin pair approximation [40]. 
2.3. Biological Testing of the Novel A. aculeatus Metabolites 
Aculenes A–C, acu-dioxomorpholine, okaramine S and epi-10,23-dihydro-24,25-dehydroaflavinine 
were tested for antifungal activity against Candida albicans. Endpoint optical density from compound 
screens were normalized with the negative controls and susceptibility evaluated as percentage 
reduction in optical density. None of the compounds showed significant antifungal activity. 
2.4. Production of Sclerotia Reveals a Highly Regulated Metabolic Profile 
It has recently been demonstrated that sclerotium production can be prompted under specific 
conditions for a number of the black aspergilla [41]. This study showed that some metabolites are 
highly upregulated inside the sclerotia, compared to the metabolites in the mycelium. A. aculeatus is 
capable of producing sclerotia in vast amounts. Production was demonstrated on CYA and YES media, 
see Figure 9. 
Analysis of extracts of sclerotia from MM, CYA and YES showed large upregulations of 
okaramines, see Figure 10. Aculenes A–C were still produced, though in smaller amounts. 
Furthermore the analysis showed that production of secalonic acids abolished on MM and CYA. The 
calbistrins were still produced and the same were acucalbistrins A–B, though in trace amounts. Some 
okaramine analogues have shown activity against silkworms [42–44] and the substantial upregulation 
of okaramines can be connected to sclerotium production as a defense mechanism to protect  
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against insects. Sclerotia are survival structures and the production is often provoked by extreme  
conditions [41,45]. 
Figure 9. The figure shows production of sclerotia on YES (left) and CYA media (right) 
after growth for 7 days at 25 °C in the dark. The sclerotia are the white to cream-colored 
structures seen among the black conidial Aspergillus heads.  
 
Figure 10. Base peak chromatograms of extraction from sclerotia (top) and plug 
extractions of A. aculeatus IBT 21030 after cultivation on YES agar for 7 days at 25 °C in 
the dark (bottom) for reference. The chromatograms are to scale. Stars indicate okaramines 
produced in the sclerotium extract.  
 
3. Experimental Section  
3.1. Fungal Growth, Strains and Media 
For standard screening the fungal strain was inoculated as three point stabs on solid media and 
incubated for seven days at 25 °C. Media was prepared as described by Samson et al. [25] The strain 
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IBT 21030 was compared to the culture ex type IBT 3244 = CBS 172.66 = ATCC 16872 = IMI 
211388 = WB 5094, in order to authenticate the identity of the isolate.  
3.2. Large Scale Extraction 
For the large scale preparation, A. aculeatus (IBT 21030) was inoculated as three point stabs on 200 
plates of solid YES medium, and incubated in the dark for 7 days at 25 °C. The fungi were harvested 
and extracted. Ten Petri plates of fungi were transferred to separate stomacher bags. To each bag  
100 mL of ethyl acetate (EtOAc) containing 1% formic acid (FA) were added and the bags were 
subsequently crushed using a stomacher for 30–60 s. After one hour the liquid phase was filtered and 
concentrated in vacuo. The stomacher bags still containing the fungi were again filled with EtOAc 
containing 1% FA, and then left overnight. The following day the solution was filtered and then 
concentrated in vacuo. The combined extract was dissolved in 800 mL methanol (MeOH) and H2O 
purified and deionized by a Millipore system through a 0.22 μm membrane filter (MQ H2O) (9:1) and 
800 mL of heptane added, whereafter the phases were separated. To the MeOH/MQ H2O phase  
800 mL MQ H2O was added, and metabolites were then extracted with 4 × 400 mL dichloromethane 
(DCM). The phases were then concentrated separately in vacuo. 
3.3. Plug Extraction 
For standard screening three plugs were taken from one colony by use of a 6 mm plug drill; one 
from the center of the colony, one from the edge near the other colonies and one from the edge as far 
away from the other colonies. The plugs were transferred to 2 mL vials and 500 µL extraction solvent 
were added. A mixture of MeOH/DCM/EtOAc (1:2:3 v/v/v) containing 1% FA was used. To each 
sample 40 μL chloramphenicol in ethanol (500 μg/mL) was added as an internal standard. The vials 
were placed in an ultrasonic bath (Branson 2510 or 3520) for 60 min. The extract was then transferred 
to a clean vial and evaporated to dryness. This was either achieved by leaving the vials in a fume hood 
over night or by applying nitrogen airflow at 25–32 °C. After evaporation 500 µL MeOH was added 
and the sample was then ultrasonicated for 20 minutes. The extract was then filtered using a 0.45 μm 
PTFE filter. 
3.4. Sclerotium Extraction 
A. aculeatus IBT 21030 was three-point inoculated on YES, CYA and MM plates and incubated at 
30 °C for ten days and then at room temperature for eight days. Sclerotia were harvested by applying 
MQ H2O to the plate and carefully harvest with Drigalski spatula. The liquid including the sclerotia 
and spores was filtred through sterilised Miracloth and washed with MQ H2O, allowing for the spores to 
pass through, while sclerotia were staying in the filter. Sclerotia were transferred to true Eppendorf tubes 
and washed with water to remove remaining spores. After evaporation of excess MQ H2O, two big and two 
small steel balls was added to each tube and the tubes were shaken at 2000 rpm for 2 × 60 s. To each tube 
40 µL chloramphenicol (internal standard) and 1 mL MeOH/DCM/EtOAc (1:2:3 v/v/v) containing 1% 
FA was added and the extract was transferred to clean 2 mL vials. The samples were ultrasonicated for 
1 h and the extract was transferred to clean vials and solvent was evaporated by applying airflow at 
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25–32 °C. The samples were redissolved in 500 µL MeOH, ultrasonicated for 20 min and filtrated to 
fresh vials using 0.45 μm PTFE filters. 
3.5. UHPLC-DAD-HRMS Analysis 
Analysis was performed using ultra-high-performance liquid chromatography (UPHLC) UV/Vis 
diode array detector (DAD) high-resolution MS (TOFMS) on a maXis 3G orthogonal acceleration 
quadrupole time of flight mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with an 
electrospray ionization (ESI) source and connected to an Ultimate 3000 UHPLC system (Dionex, 
Sunnyvale, CA, USA). The column used was a reverse-phase Kinetex 2.6-μm C18, 100 × 2.1 mm 
(Phenomenex, Torrance, CA, USA), and the column temperature was maintained at 40 °C. A linear  
water-acetonitrile (ACN) (LCMS-grade) gradient was used (both solvents were buffered with 20 mM 
FA) starting from 10% (vol/vol) ACN and increased to 100% in 10 min, maintaining this rate for 3 min 
before returning to the starting conditions in 0.1 min and staying there for 2.4 min before the following 
run. A flow rate of 0.4 mL·min−1 was used. TOFMS was performed in ESI+ with a data acquisition 
range of 10 scans per second at m/z 100–1000. The TOFMS was calibrated using Bruker Daltonics 
high precision calibration algorithm (HPC) by means of the use of the internal standard sodium 
formate, which was automatically infused before each run. UV/VIS spectra were collected at 
wavelengths from 200 to 700 nm. Data processing was performed using DataAnalysis 4.0 software 
(Bruker Daltonics). 
3.6. NMR 
The 1D and 2D spectra were recorded on a Varian Unity Inova-500 MHz spectrometer located at 
DTU, or on a Bruker Avance 800 MHz spectrometer located at the Danish Instrument Centre for NMR 
Spectroscopy of Biological Macromolecules at Carlsberg Laboratory. Spectra were acquired using 
standard pulse sequences. The deuterated solvent was DMSO-d6 and signals were referenced by 
solvent signals for DMSO-d6 at δH = 2.49 ppm and δC = 39.5 ppm. The NMR data was processed in 
MestReNova V.6.0.1–5391 or Bruker Topspin. Chemical shifts are in ppm (δ) and scalar couplings are 
reported in hertz (Hz). The sizes of the J coupling constants reported in the tables are the 
experimentally measured values from the 1D 1H and DQF-COSY spectra. There are minor variations 
in the measurements which may be explained by the uncertainty of J and the spectral digital resolution. 
Distances for the epi-10,23-dihydro-24,25-dehydroaflavinine were obtained from 2D NOESY 
experiments using the isolated spin pair approximation (ISPA) [40]. The linear range was increased by 
the method suggested by Macura et al. [46,47]. The used mixing time was 150 ms. Different mixing 
times were used to construct a buildup curve to ensure that only crosspeaks which fitted the ISPA  
were used.  
The 3J-couplings from angles in the 3D structures of epi-10,23-dihydro-24,25-dehydroaflavinine 
and the aculenes were calculated by the Haasnoot-DeLeeuw-Altona (HLA) equation and by DFT 
computations of the final structure [48,49]. 
The simulations were conducted using the program Maestro (Version 9.3.515, MMshare  
Version 2.1.515) from the Schrödinger suite. Conformational searches in implicit solvents (DMSO) 
were run by MacroModel (version 9.9, Schrödinger, LLC, New York, NY, USA, 2012) using the force 
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fields OPLS2005 and MMFFs. Monte Carlo torsional sampling was used to generate the structures and 
the minimization method was PRCG. The number of steps were 20,000, and only conformations 
within 30 kJ/mol of the found minimum were considered. The solvent DMSO was treated as a constant 
dielectric constant of 47.0. Both force fields gave similar results.  
Selected structures were further optimized by HF/3-21G using Jaguar (Jaguar, version 7.9, 2012, 
Schrödinger, LLC, New York, NY, USA,) followed by DFT (for epi-10,23-dihydro-24,25-
dehydroaflavinine) [50]. DFT calculations were carried out by Gaussian09 [51] using cam-B3LYP/6-
311++G(d,p) for optimization and B3LYP/6-31G(d,p) u+1s for calculating J-coupling constants (only 
Fermi Contact contribution considered, see reference [49]). 
3.7. Marfey’s Reaction 
Aculenes A and B (100 µg) were hydrolyzed with 6 M HCl (200 µL) in 2 mL analytical vials with 
lids, and were left at 110 °C for 22 h. The solvent was removed at a speedvac. For reference, 50 µL  
(2.5 µmol) standard L- and D-proline were prepared. To all vials 50 µL H2O, 20 µL 1 M NaHCO3 and  
100 µL 1% 1-fluoro-2,4-dinitrophenyl-5-L-alanineamide (FDAA) in acetone were added. The vials 
were left for 40 °C for 1 h. 10 µL 2 M HCl was added followed by 820 µL MeOH and HPLC-DAD-
MS data were acquired. 
3.8. Purification of Metabolites 
The DCM phase from the large scale extraction consisting of 2.375 g was absorbed onto Sepra  
ZT C18 (Phenomenex) and dried before packing into a 50 g (~66 mL) SNAP column (Biotage, 
Uppsala, Sweden) with Septra ZT C18 material. The extract was then fractionated using an Isolera 
flash purification system (Biotage). The gradient started with 15:100 MeOH/H2O in the first three 
column volumes (CV), then went to 100% MeOH over 18 CVs and stayed here for 3 CVs using a flow 
rate of 40 mL/min. MeOH was of HPLC grade and H2O was purified and deionized by Millipore 
system through 0.22 μm membrane filter (MQ H2O) and both were added 50 ppm trifluoroacetic acid 
(TFA). Fractions were automatically collected 1 CV at a time. The fractions were subjected to further 
purification on a semi-preparative HPLC, which was either a Waters 600 Controller with a 996 
photodiode array detector (Waters, Milford, MA, USA) or a Gilson 322 Controller connected to a 215 
Liquid Handler, 819 Injection Module and a 172 DAD (Gilson, Middleton, WI, USA). This was 
achieved using a Luna II C18 column (250 × 10 mm, 5 μm, Phenomenex). 50 ppm TFA was added to 
ACN of HPLC grade and MQ H2O. For choice of system, flow rate, gradients and yields see 
descriptions for the specific compound.  
Aculenes A and B. The three first Isolera flash chromatography fractions, eluding with 10%–25% 
MeOH, were subjected to further purification on the waters semi-preparative HPLC. A linear  
water-ACN gradient was used starting with 15% ACN and increasing to 100% over twenty minutes 
using a flow rate of 4 mL/min. Two compounds eluting with 54% and 56% ACN respectively, were 
collected. This yielded two pure compounds, 3.0 mg of aculene A and 3.7 mg of aculene B. 
Aculene A: HRMS: m/z = 316.1910. [M+H]+, calculated for [C19H25NO3+H]+: m/z = 316.1907.  
[α]20 D  = +0.63° (MeOH). 1H- and 13C-NMR (see Tables 1 and 2). 
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Aculene B: HRMS: m/z = 318.2068. [M+H]+, calculated for [C19H27NO3+H]+: m/z = 318.2064.  
[α]20 D  = +6.96° (MeOH). 1H- and 13C-NMR (see Tables 1 and 2). 
Aculene C. One of the Isolera flash chromatography fractions, eluding with 50% MeOH, was 
subjected to further purification on the waters semi-preparative HPLC. An isocratic water-ACN 
gradient was used starting with 40% ACN over twenty minutes using a flow rate of 4 mL/min. A 
compound eluding with 40% ACN was collected. This yielded 2.0 mg of aculene C. 
HRMS: m/z = 319.1382 [M+H]+, calculated for [C14H18O2+H]+: m/z = 319.1379. [α]20 D  = 0.00° 
(MeOH). 1H- and 13C-NMR (see Tables 1 and 2). 
Calbistrin A and C. One of the Isolera flash chromatography fractions, eluding with 100% MeOH, 
was subjected to further purification on the waters semi-preparative HPLC. An isocratic water-ACN 
method was used with 52% ACN over eighteen minutes using a flow rate of 4 mL/min. Two 
compounds eluding at 52% ACN were collected. This yielded 5.2 mg of calbistrin A and 4.6 mg of 
calbistrin C. 
Calbistrin A: HRMS: m/z = 563.2622 [M+Na]+, calculated for [C31H40O8+Na]+: m/z = 563.2615.  
[α]20 D  = +46.1° (MeOH). 1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.49 ppm): 0.77 (3H, d, J = 7.1 Hz), 
0.97 (3H, d, J = 7.1 Hz), 1.13 (3H, s), 1.22 (3H, s), 1.32 (1H, m), 1.69 (3H, s), 1.98 (3H, s), 2.02 (1H, m), 
2.30 (1H, dd, J = 13.8, 3.8 Hz), 2.37 (1H, m), 2.41 (1H, m), 2.69 (1H, dd, J = 13.8, 8.2 Hz), 2.80 (1H, 
m), 3.94 (1H, d, J = 9.4 Hz), 5.06 (1H, m, -OH), 5.10 (1H, m), 5.59 (1H, d, J = 9.6 Hz), 5.70 (1H, s), 
5.86 (1H, m), 5.88 (1H, d, J = 14.9 Hz), 5.97 (1H, d, J = 9.8 Hz), 6.05 (1H, d, J = 11.2 Hz), 6.30 (1H, 
d, J = 12.0 Hz), 6.38 (1H, d, J = 15.1 Hz), 6.68 (1H, dd, J = 15.1, 11.2 Hz), 7.51 (1H, dd, J = 14.9, 
12.0 Hz; 13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 10.9, 12.3, 13.0, 13.7, 20.6, 25.4, 26.0, 
34.7, 39.8, 43.6, 43.7, 56.2, 56.3, 68.3, 78.3, 121.2, 126.4, 127.0, 127.2, 130.8, 132.7, 133.8, 135.7, 
139.4, 140.9, 143.4, 173.9, 212.8. 
Calbistrin C: HRMS: m/z = 565.2776 [M+Na]+, calculated for [C31H42O8+Na]+: m/z = 565.2772.  
[α]20 D  = +8.67° (MeOH); 1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.49 ppm): 0.77 (3H, d, J = 7.1 Hz), 
0.95 (3H, d, J = 7.1 Hz), 1.01 (3H, s), 1.21 (1H, m), 1.27 (3H, s), 1.71 (3H, s), 1.93 (1H, m), 1.98 (3H, 
s), 2.35 (1H, m), 2.38 (1H, qin, J = 8.4), 2.56 (1H, m), 2.92 (1H, dt, J = 17.5, 7.5 Hz), 2.99 (1H, m), 
3.56 (2H, m), 3.95 (1H, dd, J = 9.4, 3.1 Hz), 5.09 (1H, br.d, J = 3.5 Hz, -OH), 5.05 (1H, s, -OH), 5.20 
(1H, m), 5.37 (1H, d, J = 9.9 Hz), 5.59 (1H, m), 5.88 (1H, d, J = 14.9 Hz), 5.90 (1H, d, J = 9.9 Hz), 
6.07 (1H, d, J = 11.1 Hz), 6.31 (1H, d, J = 12.0 Hz), 6.39 (1H, d, J = 15.1 Hz), 6.69 (1H, dd, J = 15.1, 
11.1 Hz), 7.51 (1H, dd, J = 14.9, 12.0); 13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 10.9, 
12.3, 13.0, 13.7, 20.6, 25.4, 26.0, 34.7, 39.8, 43.6, 43.7, 56.2, 56.3, 68.3, 78.3, 121.2, 126.4, 127.0, 
127.2, 130.8, 132.7, 133.8, 135.7, 139.4, 140.9, 143.4, 173.9, 212.8. 
Acu-dioxomorpholine. One of the Isolera flash chromatography fractions, eluding with 95% ACN, 
was subjected to further purification on the waters semi-preparative HPLC). A linear water-ACN 
gradient was used starting with 60% ACN increasing to 100% over twenty minutes using a flow rate of 
4 mL/min. A compound eluding with 85% ACN was collected. This yielded 2.1 mg of  
acu-dioxomorpholine. HRMS: m/z = 417.2176 [M+H]+, calculated for [C26H29N2O3+H]+: m/z = 417.2173. 
[α]20 D  = −49.23° (MeOH). 1H- and 13C-NMR (see Table 3). 
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Epi-10,23-dihydro-24,25-dehydroaflavinine. One Isolera flash chromatography fraction eluding 
with 100% MeOH, was subjected to purification on the waters semi-preparative HPLC. A gradient of 
15%–100% ACN over twenty minutes was used and the flow rate was 4 mL/min. A compound eluding 
with 100% ACN was collected. This yielded 8.7 mg of epi-10,23-dihydro-24,25-dehydroaflavinine. 
HRMS: m/z = 406.3113 [M+H]+, calculated for [C28H39NO+H]+: m/z = 406.3104. [α]20 D  = +63.58° 
(MeOH); 1H- and 13C-NMR (see Table 5). 
Okaramine S. One Isolera flash chromatography fraction, eluding with 100% MeOH, was subjected 
to purification on the Gilson semi-preparative HPLC. This was done using a gradient of 70%–100% 
ACN over fifteen minutes using a flow rate was 5 mL/min. A compound eluding with 80% ACN was 
collected. This yielded 1.7 mg of the pure compound. HRMS: m/z = 503.2447 [M+H]+, calculated for 
[C32H30N4O2+H]+: m/z = 503.2441. [α]20 D  = −15.29° (MeOH); 1H- and 13C-NMR (see Table 4). 
Okaramine J. One Isolera flash chromatography fraction, eluding with 74% MeOH, was subjected 
to purification on the waters semi-preparative HPLC. This was done using a gradient of 50%–100% 
ACN over twenty minutes using a flow rate of 4 mL/min. A compound eluding with 82% ACN was 
collected. This yielded 2.5 mg of the pure compound. HRESIMS: m/z = 525.2865 [M+H]+, calculated 
for [C32H36N4O3+H]+: m/z = 525.2860. [α]20 D  = +15.38° (MeOH); 1H-NMR (499.87 MHz, DMSO-d6, 
25 °C, 2.49 ppm): 1.52 (6H, s, H-17, H-18), 1.68 (3H, s, H-34), 1.73 (3H, s, H-35), 1.86 (1H, m,  
H-20), 2.42 (1H, dd, 13.2, 6.8, H-20'), 2.99 (1H, dd, 15.2, 9.4, H-1), 3.14 (1H, dd, 16.3, 7.1, H-31), 
3.23 (1H, dd, 16.8, 7.5, H-31'), 3.59 (1H, dd, 15.2, 4.2, H-1'), 4.46 (1H, dd, 9.1, 4.4, H-2), 4.67 (1H, 
dd, 11.3, 6.4, H-19), 5.05 (1H, dd, 10.5, 1.1, H-4), 5.08 (1H, dd, 17.4, 1.1, H-4'), 5.26 (1H, t, 7.4,  
H-32), 5.33 (1H, d, 4.5, H-29), 6.01 (1H, s , H-36), 6.12 (1H, d, 4.4, H-28), 6.22 (1H, dd, 17.4, 10.5, 
H-5), 6.32 (1H, s, H-3), 6.67 (1H, t, 7.5, H-24), 6.88 (1H, d, 7.5, H-25), 6.96 (1H, t, 7.5, H-12), 6.96 
(H-26), 7.05 (2H, H-11, H-23), 7.35 (1H, s, H-10), 7.53 (1H, s, H-13), 10.67 (1H, s, H-8); 13C-NMR 
(125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 17.5 (C-34), 24.7 (C-1), 25.2 (C-35), 27.6 (C-17,C-18), 
28.2 (C-31), 39.0 (C-6), 40.8 (C-20), 55.1 (C-2), 58.2 (C-19), 83.5 (C-29), 85.5 (C-21), 104.3 (C-15), 110.7 
(C-10), 110.9 (C-4), 117.6 (C-13), 118.4 (C-12, C-24), 118.9 (C-23), 120.0 (C-11), 121.5 (C-32), 122.7 
(C-22), 128.3 (C-14), 131.0 (C-26), 132.0 (C-33), 134.5 (C-9), 141.1 (C-7), 145.8 (C-27), 146.0 (C-5), 
167.5 (C-16), 169.7 (C-30). 
3.9. Antifungal Susceptibility Testing 
All compounds were screened for antifungal activity towards Candida albicans in accordance with 
the CLSI standards using RPMI-1640 medium adjusted to pH 7 with 0.165 M MOPS buffer [52]. The 
screening was performed as described by Holm et al. [53]. 
4. Conclusions  
Investigation of the chemical profile of Aspergillus aculeatus by UHPLC-DAD-HRMS has 
identified several novel compounds some of which have been selected, purified and their structure 
elucidated by 1D and 2D NMR spectroscopy. A novel class of related compounds – the aculenes – has 
been discovered. Aculenes A and B are hybrids containing the amino acid proline but also a fourteen 
carbon moeity we hypothesize to originate from a sesquiterpene with the loss of one carbon atom. 
Aculene C is believed to be a precursor to aculene A, missing the proline part of the molecule. 
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Moreover there is UHPLC-DAD-HRMS evidence suggesting a fourth structure, aculene D, a possible 
precursor to aculene B. Two other larger, however chemically unstable metabolites have been 
discovered. As they apparently were degrading to two known parts, aculene A and B respectively and 
calbistrin A, a tentative suggestion for their structures have been given. Two further novel compounds, 
acu-dioxomorpholine and okaramine S has also been discovered to be produced by A. aculeatus.  
Acu-dioxomorpholine has a remarkable structure, reminding of diketopiperazine, but with a lactone instead 
of the one lactame part and okaramine S displays a seven-membered ring, not previously seen in any 
reported okaramine. Furthermore the aflavinine analogue epi-10,23-dihydro-25,25-dehydroaflavinine 
was detected. Production of sclerotia was observed under specific conditions, and here an upregulation 
of okaramines was observed. Altogether the chemical profile of Aspergillus aculeatus has been 
examined and several novel compounds have been characterized. 
Supplementary Materials 
1H, DQF-COSY, HSQC, HMBC, NOESY and UV spectra for the novel compounds as well as 
suggestion for the structures of acucalbistrin A and B and elucidation of the stereochemistry of 
aculenes A–D and epi-10,23-dihydro-24,25-dehydroaflavinine are available in the supplementary. 
Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/19/8/10898/s1. 
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